JS207 a Bispecific Antibody Against PD1-VEGF in Nasopharyngeal Carcinoma

Clinical trial NCT07690787 · RECRUITING

Trial details

NCT number: NCT07690787
Sponsor: Chinese University of Hong Kong
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent/ Metastatic NPC

Start date: 2026-06-29
Primary completion: 2027-12-31
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.